meta-analysis | Q815382 |
scholarly article | Q13442814 |
P356 | DOI | 10.1038/S41598-017-13168-8 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/s41598-017-13168-8 |
P932 | PMC publication ID | 5634412 |
P698 | PubMed publication ID | 28993680 |
P50 | author | Petroula Proitsi | Q47504060 |
P2093 | author name string | Aminah Noor Ahmad | |
John Francis Powell | |||
Stefania Policicchio | |||
P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 |
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease | Q22251067 | ||
Depression and the risk of Alzheimer disease. | Q50778247 | ||
Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada. | Q52019123 | ||
Alzheimer's disease: a study of epidemiological aspects. | Q52092341 | ||
Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. | Q52884779 | ||
Anti-inflammatory drugs and Alzheimer disease. | Q53183421 | ||
Rheumatoid arthritis and senile dementia of the Alzheimer's type. | Q53190347 | ||
Alzheimer's disease and rheumatoid arthritis. | Q53316929 | ||
Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. | Q53354093 | ||
Midlife Rheumatoid Arthritis Increases the Risk of Cognitive Impairment Two Decades Later: A Population-Based Study | Q59542847 | ||
The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada | Q72829553 | ||
Population-based cohort studies | Q77376721 | ||
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs | Q26866006 | ||
The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis | Q27022403 | ||
Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins | Q28168105 | ||
Genetics of rheumatoid arthritis contributes to biology and drug discovery | Q29417000 | ||
The pathogenesis of rheumatoid arthritis | Q29614957 | ||
Type 2 diabetes as an inflammatory disease | Q29617184 | ||
A claims data-based comparison of comorbidity in individuals with and without dementia | Q30570359 | ||
Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes | Q33859600 | ||
2012 Alzheimer's disease facts and figures | Q34260109 | ||
Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease | Q34471227 | ||
Donepezil and memantine for moderate-to-severe Alzheimer's disease. | Q34636487 | ||
Co-morbidity in rheumatoid arthritis | Q35198206 | ||
Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial | Q35671005 | ||
The role of inflammation in Alzheimer's disease | Q35913633 | ||
What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? | Q36119363 | ||
Rheumatoid arthritis and cardiovascular disease | Q37140079 | ||
Results of a follow-up study to the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT). | Q37297193 | ||
Selecting instruments for Mendelian randomization in the wake of genome-wide association studies | Q37401173 | ||
Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease | Q37859679 | ||
Review: systemic inflammation and Alzheimer's disease | Q38050498 | ||
Evolution of treatment for rheumatoid arthritis | Q38065767 | ||
Immune attack: the role of inflammation in Alzheimer disease. | Q38492631 | ||
Rheumatoid arthritis and the risk of dementia: A systematic review and meta-analysis. | Q38692843 | ||
Beyond Mendelian randomization: how to interpret evidence of shared genetic predictors | Q40623861 | ||
Patterns of anti-inflammatory drug use and risk of dementia: a matched case-control study | Q40734133 | ||
Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator | Q40773355 | ||
Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression | Q40862437 | ||
Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies | Q41075378 | ||
A case-control study of Alzheimer's disease in China | Q41128795 | ||
A case-control study of Alzheimer's disease in Australia | Q41198222 | ||
A case-control study of Alzheimer's disease | Q41220542 | ||
Differential Association of Psychosocial Comorbidities With Subclinical Atherosclerosis in Rheumatoid Arthritis | Q41482717 | ||
A case-control study of dementia of the Alzheimer type | Q41500631 | ||
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement | Q42035537 | ||
Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease | Q42452339 | ||
The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study | Q45792532 | ||
Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. | Q46003173 | ||
Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis. | Q48369444 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Alzheimer's disease | Q11081 |
rheumatoid arthritis | Q187255 | ||
P304 | page(s) | 12861 | |
P577 | publication date | 2017-10-09 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Rheumatoid arthritis and risk for Alzheimer's disease: a systematic review and meta-analysis and a Mendelian Randomization study | |
P478 | volume | 7 |
Q58746581 | Alzheimer's Disease and Rheumatoid Arthritis: A Mendelian Randomization Study |
Q89425020 | Causal association between rheumatoid arthritis and a decreased risk of Alzheimer's disease : A Mendelian randomization study |
Q57816569 | Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer's Disease |
Q92193179 | Nature's Derivative(s) as Alternative Anti-Alzheimer's Disease Treatments |
Q90117853 | Rheumatoid arthritis and neurodegenerative dementia: a nested case-control study and a follow-up study using a national sample cohort |
Q99585428 | Using Mendelian randomization to understand and develop treatments for neurodegenerative disease |
Search more.